You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anticancer agent

Showing 1 - 25 of 7,054
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023

Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

Active, not recruiting
  • Hepatocellular Carcinoma
  • +11 more
  • Part 1 TPST-1120
  • +3 more
  • San Francisco, California
  • +10 more
Nov 1, 2022

Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in Nashville (Patient-reported outcome measure,

Recruiting
  • Chronic Myeloid Leukemia
  • +3 more
  • Patient-reported outcome measure
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 1, 2022

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Glioma, Glioblastoma Trial in Norway, Sweden (Disulfiram, Copper, Alkylating Agents)

Completed
  • Glioma
  • Glioblastoma
  • Trondheim, Norway
  • +7 more
Mar 16, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Embolization, Infusion of anticancer agent, Infusion of mixture of anticancer agent

Completed
  • Hepatocellular Carcinoma
  • Embolization
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Mar 5, 2019

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

Recruiting
  • Solid Tumor
  • +7 more
  • Duarte, California
  • +11 more
Jan 6, 2023

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)

Not yet recruiting
  • Desmoid Tumor
  • Palo Alto, California
    Stanford University
Jul 7, 2023

Malignant Tumor Trial in Chendu (EBV immunological agent)

Recruiting
  • Malignant Tumor
  • EBV immunological agent
  • Chendu, Sichuan, China
    West China Hospital
Jan 31, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

Terminated
  • Chronic Myeloid Leukemia
  • +2 more
  • Patient Reported Outcome Measure (PROM)
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 21, 2022

Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an

Recruiting
  • Metastatic Solid Tumor Cancer
  • Dose escalation, first-in-human phase I clinical trial with an Expansion phase
  • Caen, France
  • +2 more
Oct 11, 2022

Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
  • (no location specified)
Feb 28, 2023

Advanced Solid Tumor, PIK3CA Mutation, PTEN Loss of Function Mutation Trial in United States (Serabelisib, Insulin Suppressing

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 25, 2022

Colorectal Cancer, Hepatic Metastases Trial in Tours (radiation, other, drug)

Completed
  • Colorectal Cancer
  • Hepatic Metastases
  • MRI
  • +3 more
  • Tours, France
    Service d'Hépatogastro-entérologie CHRU de TOURS
Jan 6, 2023

Adult Solid Tumor Trial in Canada, Germany, United States (SQZ-PBMC-HPV, Atezolizumab, Ipilimumab)

Active, not recruiting
  • Adult Solid Tumor
  • SQZ-PBMC-HPV
  • +3 more
  • Scottsdale, Arizona
  • +12 more
Jan 17, 2023

Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

Completed
  • Recurrent Neuroendocrine Tumor
  • Metastatic Neuroendocrine Tumor
  • Cleveland, Ohio
    Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022

Advanced Solid Tumor Trial in Seongnam, Seoul (ABL103)

Recruiting
  • Advanced Solid Tumor
  • Seongnam, Seoul, Korea, Republic of
  • +2 more
Nov 13, 2023

Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Patient-Derived Tumor Organoids
  • Hong Kong, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Oct 12, 2023

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Colorectal Cancer, Triple Negative Breast Cancer, Gastric Cancer Trial in United States (navicixizumab+paclitaxel,

Recruiting
  • Colorectal Cancer
  • +3 more
  • navicixizumab+paclitaxel
  • +2 more
  • Hot Springs, Arkansas
  • +5 more
Aug 9, 2022